​

Funding Round

Series A - Cyto-Facto

Series A - Cyto-Facto

Investment Firm

Overview

Cyto-Facto is a biotechnology company that develops and manufactures CAR-T cell therapies and mesenchymal stem cell products.

Announced Date

Apr 22, 2024

Funding Type

Series A

Highlights

Location

Asia

Social

N/A

Investor Lead

MPower Partners

MPower Partners

MPower Partners is a early_stage_venture and late_stage_venture firm.

Participant Investors

7

Investor Name
Participant InvestorMPower Partners
Participant InvestorSMBC Venture Capital
Participant InvestorMitsubishi Corporation
Participant InvestorAsahi Kasei
Participant InvestorMizuho Capital

Round Details and Background

Cyto-Facto raised $7621788 on 2024-04-22 in Series A

Cyto-Facto is a biotechnology company that develops and manufactures CAR-T cell therapies and mesenchymal stem cell products.

Company Funding History

1

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Apr 22, 2024
Series A - Cyto-Facto
7-7.6M

Recent Activity

There is no recent news or activity for this profile.